5D9-26480-56844
3 vaccinations
4 coded responses
24 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 448 / OH
- Registered
- 2022-07-02
- Relationship
- Child or adolescent in my care
- Guardian
- SH9-12694-27715
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-27
Dose 1 — Pfizer-BioNTech
-
2022-07-02
Registered in v-safe
-
2022-07-02
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Fever · Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2022-07-03
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · None · Be unable to work or attend schoolAdult check-in
- 2022-07-04
- 2022-07-11
-
2022-07-19
Dose 2 — Pfizer-BioNTech
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-08-02
- 2022-08-09
- 2022-08-18
- 2022-08-23
- 2022-08-30
-
2022-09-20
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-26
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Croup infectious, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Developed croup, COVID negative 2 days after vaccineMedDRA releases: 2024-11 · check-in free text available
- 2022-09-29
-
2022-10-05
Survey response — day 14, dose 3, dependentMedDRA: Croup infectious, Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Croup and coldMedDRA releases: 2024-11 · check-in free text available
- 2022-10-11
-
2022-10-18
Survey response — day 28, dose 3, dependentMedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-10-25
- 2022-11-01
-
2022-12-20
Survey response — 3 months, dose 3, dependentMedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Minor coldsMedDRA releases: 2024-11 · check-in free text available
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-27 | Pfizer-BioNTech | No |
| 2 | 2022-07-19 | Pfizer-BioNTech | No |
| 3 | 2022-09-20 | Pfizer-BioNTech | Flu |
Free text
Release 12 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Developed croup, COVID negative 2 days after vaccine
Release 12 — day 14, dose 3, dependent
Symptoms: Croup and cold
Release 12 — day 28, dose 3, dependent
Symptoms: Cold symptoms
Release 12 — 3 months, dose 3, dependent
Symptoms: Minor colds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Croup infectious | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Croup infectious | · | · | ✓ |
| SRO | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release